Association between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal study
<p><strong>Background: </strong>Obesity predominantly affects populations in high-income countries and those countries facing epidemiological transition. The risk of childhood obesity is increased among infants who had overweight or obesity at birth, but in low-resource se...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2022
|
| _version_ | 1797109269168914432 |
|---|---|
| author | Villar, J Ochieng, R Gunier, RB Papageorghiou, AT Rauch, S McGready, R Gauglitz, JM Barros, FC Vatish, M Fernandes, M Zammit, V Carrara, VI Munim, S Craik, R Barsosio, HC Carvalho, M Berkley, JA Ismail, LIC Norris, SA Tshivuila-Matala, COO Nosten, F Ohuma, EO Stein, A Lambert, A Winsey, A Uauy, R Eskenazi, B Bhutta, ZA Kennedy, SH |
| author_facet | Villar, J Ochieng, R Gunier, RB Papageorghiou, AT Rauch, S McGready, R Gauglitz, JM Barros, FC Vatish, M Fernandes, M Zammit, V Carrara, VI Munim, S Craik, R Barsosio, HC Carvalho, M Berkley, JA Ismail, LIC Norris, SA Tshivuila-Matala, COO Nosten, F Ohuma, EO Stein, A Lambert, A Winsey, A Uauy, R Eskenazi, B Bhutta, ZA Kennedy, SH |
| author_sort | Villar, J |
| collection | OXFORD |
| description | <p><strong>Background: </strong>Obesity predominantly affects populations in high-income countries and those countries facing epidemiological transition. The risk of childhood obesity is increased among infants who had overweight or obesity at birth, but in low-resource settings one in five infants are born small for gestational age. We aimed to study the relationships between: (1) maternal metabolite signatures; (2) fetal abdominal growth; and (3) postnatal growth, adiposity, and neurodevelopment.</p>
<p><strong>Methods: </strong>In the prospective, multinational, observational INTERBIO-21st fetal study, conducted in maternity units in Pelotas (Brazil), Nairobi (Kenya), Karachi (Pakistan), Soweto (South Africa), Mae Sot (Thailand), and Oxford (UK), we enrolled women (≥18 years, with a BMI of less than 35 kg/m<sup>2</sup>, natural conception, and a singleton pregnancy) who initiated antenatal care before 14 weeks’ gestation. Ultrasound scans were performed every 5±1 weeks until delivery to measure fetal growth and feto–placental blood flow, and we used finite mixture models to derive growth trajectories of abdominal circumference. The infants’ health, growth, and development were monitored from birth to age 2 years. Early pregnancy maternal blood and umbilical cord venous blood samples were collected for untargeted metabolomic analysis.</p>
<p><strong>Findings: </strong>From Feb 8, 2012, to Nov 30, 2019, we enrolled 3598 pregnant women and followed up their infants to 2 years of age. We identified four ultrasound-derived trajectories of fetal abdominal circumference growth that accelerated or decelerated within a crucial 20–25 week gestational age window: faltering growth, early accelerating growth, late accelerating growth, and median growth tracking. These distinct phenotypes had matching feto–placental blood flow patterns throughout pregnancy, and different growth, adiposity, vision, and neurodevelopment outcomes in early childhood. There were 709 maternal metabolites with positive effect for the faltering growth phenotype and 54 for the early accelerating growth phenotype; 31 maternal metabolites had a negative effect for the faltering growth phenotype and 76 for the early accelerating growth phenotype. Metabolites associated with the faltering growth phenotype had statistically significant odds ratios close to 1·5 (ie, suggesting upregulation of metabolic pathways of impaired fetal growth). The metabolites had a reciprocal relationship with the early accelerating growth phenotype, with statistically significant odds ratios close to 0.6 (ie, suggesting downregulation of fetal growth acceleration). The maternal metabolite signatures included 5-hydroxy-eicosatetraenoic acid, and 11 phosphatidylcholines linked to oxylipin or saturated fatty acid sidechains. The fungicide, chlorothalonil, was highly abundant in the early accelerating growth phenotype group.</p>
<p><strong>Interpretation: </strong>Early pregnancy lipid biology associated with fetal abdominal growth trajectories is an indicator of patterns of growth, adiposity, vision, and neurodevelopment up to the age of 2 years. Our findings could contribute to the earlier identification of infants at risk of obesity.</p> |
| first_indexed | 2024-03-07T07:39:26Z |
| format | Journal article |
| id | oxford-uuid:786fe591-1eb2-43b8-acd5-63666a2b8d6c |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:39:26Z |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:786fe591-1eb2-43b8-acd5-63666a2b8d6c2023-04-17T06:50:58ZAssociation between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:786fe591-1eb2-43b8-acd5-63666a2b8d6cEnglishSymplectic ElementsElsevier2022Villar, JOchieng, RGunier, RBPapageorghiou, ATRauch, SMcGready, RGauglitz, JMBarros, FCVatish, MFernandes, MZammit, VCarrara, VIMunim, SCraik, RBarsosio, HCCarvalho, MBerkley, JAIsmail, LICNorris, SATshivuila-Matala, COONosten, FOhuma, EOStein, ALambert, AWinsey, AUauy, REskenazi, BBhutta, ZAKennedy, SH<p><strong>Background: </strong>Obesity predominantly affects populations in high-income countries and those countries facing epidemiological transition. The risk of childhood obesity is increased among infants who had overweight or obesity at birth, but in low-resource settings one in five infants are born small for gestational age. We aimed to study the relationships between: (1) maternal metabolite signatures; (2) fetal abdominal growth; and (3) postnatal growth, adiposity, and neurodevelopment.</p> <p><strong>Methods: </strong>In the prospective, multinational, observational INTERBIO-21st fetal study, conducted in maternity units in Pelotas (Brazil), Nairobi (Kenya), Karachi (Pakistan), Soweto (South Africa), Mae Sot (Thailand), and Oxford (UK), we enrolled women (≥18 years, with a BMI of less than 35 kg/m<sup>2</sup>, natural conception, and a singleton pregnancy) who initiated antenatal care before 14 weeks’ gestation. Ultrasound scans were performed every 5±1 weeks until delivery to measure fetal growth and feto–placental blood flow, and we used finite mixture models to derive growth trajectories of abdominal circumference. The infants’ health, growth, and development were monitored from birth to age 2 years. Early pregnancy maternal blood and umbilical cord venous blood samples were collected for untargeted metabolomic analysis.</p> <p><strong>Findings: </strong>From Feb 8, 2012, to Nov 30, 2019, we enrolled 3598 pregnant women and followed up their infants to 2 years of age. We identified four ultrasound-derived trajectories of fetal abdominal circumference growth that accelerated or decelerated within a crucial 20–25 week gestational age window: faltering growth, early accelerating growth, late accelerating growth, and median growth tracking. These distinct phenotypes had matching feto–placental blood flow patterns throughout pregnancy, and different growth, adiposity, vision, and neurodevelopment outcomes in early childhood. There were 709 maternal metabolites with positive effect for the faltering growth phenotype and 54 for the early accelerating growth phenotype; 31 maternal metabolites had a negative effect for the faltering growth phenotype and 76 for the early accelerating growth phenotype. Metabolites associated with the faltering growth phenotype had statistically significant odds ratios close to 1·5 (ie, suggesting upregulation of metabolic pathways of impaired fetal growth). The metabolites had a reciprocal relationship with the early accelerating growth phenotype, with statistically significant odds ratios close to 0.6 (ie, suggesting downregulation of fetal growth acceleration). The maternal metabolite signatures included 5-hydroxy-eicosatetraenoic acid, and 11 phosphatidylcholines linked to oxylipin or saturated fatty acid sidechains. The fungicide, chlorothalonil, was highly abundant in the early accelerating growth phenotype group.</p> <p><strong>Interpretation: </strong>Early pregnancy lipid biology associated with fetal abdominal growth trajectories is an indicator of patterns of growth, adiposity, vision, and neurodevelopment up to the age of 2 years. Our findings could contribute to the earlier identification of infants at risk of obesity.</p> |
| spellingShingle | Villar, J Ochieng, R Gunier, RB Papageorghiou, AT Rauch, S McGready, R Gauglitz, JM Barros, FC Vatish, M Fernandes, M Zammit, V Carrara, VI Munim, S Craik, R Barsosio, HC Carvalho, M Berkley, JA Ismail, LIC Norris, SA Tshivuila-Matala, COO Nosten, F Ohuma, EO Stein, A Lambert, A Winsey, A Uauy, R Eskenazi, B Bhutta, ZA Kennedy, SH Association between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal study |
| title | Association between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal study |
| title_full | Association between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal study |
| title_fullStr | Association between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal study |
| title_full_unstemmed | Association between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal study |
| title_short | Association between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal study |
| title_sort | association between fetal abdominal growth trajectories maternal metabolite signatures early in pregnancy and childhood growth and adiposity prospective observational multinational interbio 21st fetal study |
| work_keys_str_mv | AT villarj associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT ochiengr associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT gunierrb associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT papageorghiouat associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT rauchs associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT mcgreadyr associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT gauglitzjm associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT barrosfc associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT vatishm associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT fernandesm associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT zammitv associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT carraravi associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT munims associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT craikr associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT barsosiohc associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT carvalhom associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT berkleyja associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT ismaillic associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT norrissa associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT tshivuilamatalacoo associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT nostenf associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT ohumaeo associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT steina associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT lamberta associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT winseya associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT uauyr associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT eskenazib associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT bhuttaza associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy AT kennedysh associationbetweenfetalabdominalgrowthtrajectoriesmaternalmetabolitesignaturesearlyinpregnancyandchildhoodgrowthandadiposityprospectiveobservationalmultinationalinterbio21stfetalstudy |